2,4-Dichloro-6-methylpyrimidin-5-amine, 95.0%, 100g

PONESIMOD, 98%, 250mg

1-(tert-Butoxycarbonyl)-4-(1H-pyrazol-1-yl)piperidine-4-carboxylic acid, 95%, 500mg

Acetic acid, (2-methoxyphenoxy)-, methyl ester, 95.0%, 5g

1-(3-(BENZO[D]THIAZOL-2-YL)-4-HYDROXYPHENYL)-3-PHENYLUREA, 95.0%, 250mg

cis-Diammineplatinum(II) Dichloride100mg

METHYL 4-((2S,4S)-4-ETHOXYPIPERIDIN-2-YL)BENZOATE, 95%, 5g

2,2,6,6-Tetramethylpiperidinoxy free radical, 99.0%, 1kg

4-oxo-6-(trifluoromethyl)-1,4-dihydropyridine-3-carboxylic acid, 98%, 1g

Isobutil éster de ácido acético, mínimo 99 %, para síntesis, 500 ml, envase de vidrio

5-((4-(Diethylcarbamoyl)phenyl)amino)-5-oxopentanoic acid, 97%, 100mg

3,5-DIBROMO-4-METHOXYPYRIDIN-2-AMINE, 95%, 1g

Methyl 3-bromo-4,5-dichlorobenzoate, 95.0%, 250mg